WO2012018881A3 - Methods and compositions for the regulation of rna - Google Patents

Methods and compositions for the regulation of rna

Info

Publication number
WO2012018881A3
WO2012018881A3 PCT/US2011/046365 US2011046365W WO2012018881A3 WO 2012018881 A3 WO2012018881 A3 WO 2012018881A3 US 2011046365 W US2011046365 W US 2011046365W WO 2012018881 A3 WO2012018881 A3 WO 2012018881A3
Authority
WO
Grant status
Application
Patent type
Prior art keywords
compositions
methods
rna
regulation
lncrna
Prior art date
Application number
PCT/US2011/046365
Other languages
French (fr)
Other versions
WO2012018881A2 (en )
Inventor
Brian Bettencourt
Gregory Hinkle
Kenneth S. Koblan
Muthiah Manoharan
Stuart Pollard
Donna T. Ward
Original Assignee
Alnylam Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • C12N2320/11Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids

Abstract

The invention relates to compositions and methods of modulating the status, activity or expression of long intervening non-coding RNA transcript (lncRNA) targets.
PCT/US2011/046365 2010-08-03 2011-08-03 Methods and compositions for the regulation of rna WO2012018881A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US37041410 true 2010-08-03 2010-08-03
US61/370,414 2010-08-03

Publications (2)

Publication Number Publication Date
WO2012018881A2 true WO2012018881A2 (en) 2012-02-09
WO2012018881A3 true true WO2012018881A3 (en) 2012-08-09

Family

ID=45560043

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/046365 WO2012018881A3 (en) 2010-08-03 2011-08-03 Methods and compositions for the regulation of rna

Country Status (1)

Country Link
WO (1) WO2012018881A3 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9175291B2 (en) 2012-10-11 2015-11-03 Isis Pharmaceuticals Inc. Modulation of androgen receptor expression
US9328346B2 (en) 2010-11-12 2016-05-03 The General Hospital Corporation Polycomb-associated non-coding RNAs

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9920317B2 (en) 2010-11-12 2018-03-20 The General Hospital Corporation Polycomb-associated non-coding RNAs
WO2013173652A1 (en) * 2012-05-16 2013-11-21 Rana Therapeutics, Inc. Compositions and methods for modulating gene expression
EP2943579A4 (en) * 2013-01-10 2016-10-19 Ge Healthcare Dharmacon Inc Templates, libraries, kits and methods for generating molecules
EP2813578A1 (en) * 2013-06-14 2014-12-17 Prestizia Methods for detecting an infectious agent, in particular HIV1, using long noncoding RNA
EP3178928A1 (en) 2013-08-07 2017-06-14 Regeneron Pharmaceuticals, Inc. Pint knockout mouse exhibiting a premature aging-associated phenotype
US20160194625A1 (en) 2013-09-03 2016-07-07 Moderna Therapeutics, Inc. Chimeric polynucleotides
CA2926218A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
US20170210788A1 (en) 2014-07-23 2017-07-27 Modernatx, Inc. Modified polynucleotides for the production of intrabodies
EP3286310A1 (en) * 2015-04-24 2018-02-28 California Institute of Technology Reactivation of x chromosome genes
CN105567806A (en) * 2015-12-07 2016-05-11 中山大学附属第一医院 Application of NR_027669.1 in detecting fungal infections of organ transplant patients and kit
CN105567804A (en) * 2015-12-07 2016-05-11 中山大学附属第一医院 Application of NR_073415.2 in detecting cytomegalovirus infections of organ transplant patients and kit

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050064454A1 (en) * 2000-06-05 2005-03-24 Young Paul E. Cancer gene determination and therapeutic screening using signature gene sets
US20050153337A1 (en) * 2003-04-03 2005-07-14 Muthiah Manoharan iRNA conjugates
US20060134663A1 (en) * 2004-11-03 2006-06-22 Paul Harkin Transcriptome microarray technology and methods of using the same
US20060240093A1 (en) * 2003-07-16 2006-10-26 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050064454A1 (en) * 2000-06-05 2005-03-24 Young Paul E. Cancer gene determination and therapeutic screening using signature gene sets
US20050153337A1 (en) * 2003-04-03 2005-07-14 Muthiah Manoharan iRNA conjugates
US20060240093A1 (en) * 2003-07-16 2006-10-26 Protiva Biotherapeutics, Inc. Lipid encapsulated interfering rna
US20060134663A1 (en) * 2004-11-03 2006-06-22 Paul Harkin Transcriptome microarray technology and methods of using the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FORREST ET AL.: "Annotating non-coding transcription using functional genomics strategies.", BRIEF FUNCT. GENOMIC PROTEOMIC, vol. 8, no. 6, 2009, pages 437 - 443 *
GUPTA ET AL.: "Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.", NATURE, vol. 464, no. 7291, 15 April 2010 (2010-04-15), pages 1071 - 1076, XP055037476, DOI: doi:10.1038/nature08975 *
KHALIL ET AL.: "Many human large intergenic noncoding RNAs associate with chromatin- modifying complexes and affect gene expression.", PROC. NATL. ACAD. SCI., vol. 106, no. 28, 2009, pages 11667 - 11672, XP055073351, DOI: doi:10.1073/pnas.0904715106 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328346B2 (en) 2010-11-12 2016-05-03 The General Hospital Corporation Polycomb-associated non-coding RNAs
US9175291B2 (en) 2012-10-11 2015-11-03 Isis Pharmaceuticals Inc. Modulation of androgen receptor expression

Also Published As

Publication number Publication date Type
WO2012018881A2 (en) 2012-02-09 application

Similar Documents

Publication Publication Date Title
WO2009089494A3 (en) Pharmaceutical compositions
WO2012103810A1 (en) Certain chemical entities, compositions, and methods
WO2011090760A4 (en) Heteroaryl compounds and uses thereof
WO2011031896A3 (en) Pi3 kinase inhibitors and uses thereof
WO2014100764A3 (en) Methods of inhibiting prmt5
WO2011098979A3 (en) Radioresistant alga of the coccomyxa genus
WO2014011900A3 (en) Inhibitors of the fibroblast growth factor receptor
WO2012037299A3 (en) Fatty acid synthase inhibitors
WO2010149322A8 (en) Polyploid plants
WO2011130615A3 (en) Preparation of lacosamide
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
WO2012138981A3 (en) New intermediates and processes for preparing ticagrelor
WO2009115084A3 (en) Pyrrolopyrimidine derivatives, and use thereof
WO2013016205A3 (en) Compositions and methods for reducing the incidence of equine digestive disorders
WO2011146819A3 (en) METHODS AND COMPOSITIONS FOR TREATMENT NF-κB-MEDIATED AND α7 INTEGRIN-SUPPRESSED DISEASES
EP2729123B8 (en) Cannabinoid receptor binding agents, compositions and methods
WO2014006025A3 (en) Marker of pathogenicity in salmonella
WO2011084553A3 (en) Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
WO2014008263A3 (en) Paramyxovirus and methods of use
EP2714081A4 (en) Methods, compositions, and kits for the treatment of cancer
WO2010065889A3 (en) Cyclobutanemethanamine inhibitors of monomine reuptake
WO2013155465A8 (en) Substituted xanthine derivatives
WO2011156654A3 (en) Pathways characterization of cells
WO2012078618A3 (en) Predicting and treating diabetic complications
WO2012047582A3 (en) Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11815240

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11815240

Country of ref document: EP

Kind code of ref document: A2